PMDA Japan Drug Precaution Revisions
GovPing monitors PMDA Japan Drug Precaution Revisions for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 2 changes logged to date.
Thursday, March 12, 2026
Japan PMDA Drug Precaution Revisions for FY2025
The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has published a list of drug precaution revisions for Fiscal Year 2025, detailing updates for various nonproprietary drug names. These revisions are effective on specific dates in late 2025 and early 2026, with associated investigation summaries available.
PMDA Japan Drug Precaution Revisions
The PMDA Japan has updated drug precautions for several medications, including Andexanet alfa, Topiramate, and various VEGF/VEGFR inhibitors. These revisions reflect new safety information and investigation results, impacting the labeling and handling of these drugs.
Get daily alerts for PMDA Japan Drug Precaution Revisions
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source details
Activity
Browse Categories
Get PMDA Japan Drug Precaution Revisions alerts
We'll email you when PMDA Japan Drug Precaution Revisions publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.